• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
POH
Click for more information
0.00% 0.0¢

PROGRESS 2023-2 TRUST - Announcements

Market Cap $0  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
POH Response to ASX Price Query-POH.AX PRICE SENSITIVE23/09/16
POH Phosphagenics Updates Long Term Incentive Scheme-POH.AX PRICE SENSITIVE12/09/16
POH Phosphagenics Begins Feed Efficiency Study in Poultry-POH.AX PRICE SENSITIVE31/08/16
POH Phosphagenics Half Year Financial Results-POH.AX 28/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX PRICE SENSITIVE28/08/16
POH Phosphagenics Half Year Financial Results-POH.AX 26/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX PRICE SENSITIVE26/08/16
POH CEO Quarterly Update Teleconference-POH.AX 29/07/16
POH Phosphagenics July Newsletter-POH.AX 29/07/16
POH Phosphagenics Completes Grower/Finisher Pig Study-POH.AX PRICE SENSITIVE30/06/16
POH Phosphagenics Initiates Cattle Study-POH.AX PRICE SENSITIVE01/06/16
POH Initial Director's Interest Notice-POH.AX 23/05/16
POH Final Director's Interest Notice-POH.AX 20/05/16
POH 2016 Annual General Meeting Results-POH.AX 19/05/16
POH Appointment of Non-Executive Director-POH.AX 19/05/16
POH 2016 AGM Chairman and CEO Presentations-POH.AX 19/05/16
POH Retirement of Non-Executive Director-POH.AX 18/05/16
POH Phosphagenics Expands Licence Agreement for Diclofenac Gel-POH.AX PRICE SENSITIVE18/05/16
POH Phosphagenics Expands Japanese Option to Oxycodone Patch-POH.AX PRICE SENSITIVE17/05/16
POH Ceasing to be a substantial holder-POH.AX 03/05/16
POH Phosphagenics Signs Japanese License Option and R&D Alliance-POH.AX PRICE SENSITIVE29/04/16
POH Appendix 4G - Corporate Governance Statement-POH.AX 15/04/16
POH Notice of Annual General Meeting and Proxy Form-POH.AX 15/04/16
POH 2015 Annual Report-POH.AX 15/04/16
POH Receipt of $2.4m R&D Tax IncentivePRICE SENSITIVE29/03/16
POH Appendix 4E and Annual Financial ReportPRICE SENSITIVE29/02/16
POH Securities Trading Policy24/02/16
POH CEO Quarterly Update Teleconference16/02/16
POH Phosphagenics - February 2016 Newsletter16/02/16
POH Phosphagenics Announces Results of TPM/Oxycodone Ph2a TrialPRICE SENSITIVE29/01/16
POH Positive Results for Weaner Pig Feed Efficiency TrialPRICE SENSITIVE20/01/16
POH Appendix 3B Notice Reconciliation of Non-Quoted Securities12/01/16
POH Phosphagenics Initiates Arbitration Against Mylan06/01/16
POH Change in substantial holding06/01/16
POH Response to ASX Price QueryPRICE SENSITIVE05/01/16
POH Phosphagenics' PHN Trial Completes Enrolment and DosingPRICE SENSITIVE17/12/15
POH Change of Company Secretary04/12/15
POH Phosphagenics Initiates Grower/Finisher Pig StudyPRICE SENSITIVE03/12/15
POH Change in substantial holding13/11/15
POH Receipt of R&D Tax IncentivePRICE SENSITIVE11/11/15
POH Change in substantial holding09/11/15
POH Phosphagenics Investor presentation - Australian Roadshow04/11/15
POH Change in substantial holding02/11/15
POH Phosphagenics - October 2015 Newsletter28/10/15
POH Quarterly Shareholder Update teleconference23/10/15
POH Development Agreement for TPM Oxymorphone PatchPRICE SENSITIVE22/10/15
POH Phosphagenics RestructuresPRICE SENSITIVE12/10/15
POH Phosphagenics Begins Animal Health & Nutrition ProgramPRICE SENSITIVE28/09/15
POH June 2015 Half-year Appendix 4D and Financial reportPRICE SENSITIVE31/08/15
POH Appendix 3Y Change in Directors Interest Dr R Murdoch06/08/15
POH Reconciliation of Non-quoted Securities and Appendix 3B06/08/15
POH Appendix 3Z - Final Directors Interest Notice - Mr H Rosen10/07/15
POH Phosphagenics July 2015 Newsletter09/07/15
POH Executive Director and Founder Steps Down08/07/15
POH POH - Quarterly Shareholder Update - Teleconference01/07/15
POH Appointment of Consultant to Assist in Commercialising TPM09/06/15
POH 2015 Annual General Meeting Results19/05/15
POH 2015 AGM Chairmans and CEO Presentations18/05/15
POH Final Directors Interest Notice - Appendix 3Z14/05/15
POH Oxymorphone Patch Program UpdatePRICE SENSITIVE14/05/15
POH Resignation of Chairman - Mr L Gozlan12/05/15
POH 2014 Annual Report and 2015 AGM documentation17/04/15
POH Appendix 3X Notices - 317/04/15
POH POH Oxycodone Patch Dosing in Phase 2 Clinical TrialPRICE SENSITIVE17/04/15
POH Phosphagenics Appoints Three New Directors13/04/15
POH Animal Health Nutrition License Agreement signedPRICE SENSITIVE25/03/15
POH Response to ASX Price QueryPRICE SENSITIVE12/03/15
POH December 2014 Preliminary Final Report and Financial ReportPRICE SENSITIVE26/02/15
POH POH Decides to Put its BioElixia Cosmetic Brand Up For SalePRICE SENSITIVE25/02/15
POH Phosphagenics Appoints Dr Ross Murdoch as CEOPRICE SENSITIVE14/01/15
POH Ethics Approval -Topical Phase 2 TPM Oxycodone Patch TrialPRICE SENSITIVE08/12/14
POH Phosphagenics November Newsletter05/11/14
POH Phosphagenics Launches New Logo and Website05/11/14
POH Director's Change of Interest Notice - Dr G Cauwenbergh15/10/14
POH Successful Results -Phase 2 TPM Trentinoin Gel Study on AcnePRICE SENSITIVE07/10/14
POH Form 604 Change Substantial Shareholding Mr H Rosen01/09/14
POH Section 708A Notice - Equity Raising - 51 million new shares01/09/14
POH Confirmation - Allotment of 51 million new ordinary shares01/09/14
POH June 2014 App 4D Half Yearly Report and Financial ReportPRICE SENSITIVE27/08/14
POH General Meeting Results26/08/14
POH First IND Enabling Study for TPM Oxymorphone CompletedPRICE SENSITIVE11/08/14
POH Allotment of Share Purchase Plan New Shares06/08/14
POH Share Purchase Plan Closed Oversubscribed05/08/14
POH Opioid Patch Program UpdatePRICE SENSITIVE28/07/14
POH Share Purchase Plan Extension of Closing Date to 01 08 1425/07/14
POH General Meeting Documentation - Proxy Form25/07/14
POH Form 605 Notice of ceasing to be a substantial shareholder23/07/14
POH Section 708A Notice - Equity Raising - 153 million shares18/07/14
POH Confirmation - allotment of 153 million new shares18/07/14
POH POH - Share Purchase Plan documentation15/07/14
POH POH - SPP - Notice Under ASIC Class Order 09-42511/07/14
POH Phosphagenics Appendix 3B Notice - Equity Capital Raising11/07/14
POH Phosphagenics $19.3 million Capital raisingPRICE SENSITIVE11/07/14
POH Trading HaltPRICE SENSITIVE09/07/14
POH Strengthens Partnership with Le Metier de Beaute Cosmetics12/06/14
POHAppendix 3Y Notices -3- Change in Directors Interest03/06/14
POHAppendix 3B Notice - Issue of Options to Directors03/06/14
POH2014 AGM Results23/05/14
POH2014 AGM Addresses - Presentations23/05/14
POHPOH Topical Oxycodone Patch Alleviates Pain in RacehorsesPRICE SENSITIVE21/05/14
POH Response to ASX Price Query-POH.AX
23/09/16PRICE SENSITIVE
POH Phosphagenics Updates Long Term Incentive Scheme-POH.AX
12/09/16PRICE SENSITIVE
POH Phosphagenics Begins Feed Efficiency Study in Poultry-POH.AX
31/08/16PRICE SENSITIVE
POH Phosphagenics Half Year Financial Results-POH.AX
28/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX
28/08/16PRICE SENSITIVE
POH Phosphagenics Half Year Financial Results-POH.AX
26/08/16
POH June 2016 Half-year Financial Report and Appendix 4D-POH.AX
26/08/16PRICE SENSITIVE
POH CEO Quarterly Update Teleconference-POH.AX
29/07/16
POH Phosphagenics July Newsletter-POH.AX
29/07/16
POH Phosphagenics Completes Grower/Finisher Pig Study-POH.AX
30/06/16PRICE SENSITIVE
POH Phosphagenics Initiates Cattle Study-POH.AX
01/06/16PRICE SENSITIVE
POH Initial Director's Interest Notice-POH.AX
23/05/16
POH Final Director's Interest Notice-POH.AX
20/05/16
POH 2016 Annual General Meeting Results-POH.AX
19/05/16
POH Appointment of Non-Executive Director-POH.AX
19/05/16
POH 2016 AGM Chairman and CEO Presentations-POH.AX
19/05/16
POH Retirement of Non-Executive Director-POH.AX
18/05/16
POH Phosphagenics Expands Licence Agreement for Diclofenac Gel-POH.AX
18/05/16PRICE SENSITIVE
POH Phosphagenics Expands Japanese Option to Oxycodone Patch-POH.AX
17/05/16PRICE SENSITIVE
POH Ceasing to be a substantial holder-POH.AX
03/05/16
POH Phosphagenics Signs Japanese License Option and R&D Alliance-POH.AX
29/04/16PRICE SENSITIVE
POH Appendix 4G - Corporate Governance Statement-POH.AX
15/04/16
POH Notice of Annual General Meeting and Proxy Form-POH.AX
15/04/16
POH 2015 Annual Report-POH.AX
15/04/16
POH Receipt of $2.4m R&D Tax Incentive
29/03/16PRICE SENSITIVE
POH Appendix 4E and Annual Financial Report
29/02/16PRICE SENSITIVE
POH Securities Trading Policy
24/02/16
POH CEO Quarterly Update Teleconference
16/02/16
POH Phosphagenics - February 2016 Newsletter
16/02/16
POH Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial
29/01/16PRICE SENSITIVE
POH Positive Results for Weaner Pig Feed Efficiency Trial
20/01/16PRICE SENSITIVE
POH Appendix 3B Notice Reconciliation of Non-Quoted Securities
12/01/16
POH Phosphagenics Initiates Arbitration Against Mylan
06/01/16
POH Change in substantial holding
06/01/16
POH Response to ASX Price Query
05/01/16PRICE SENSITIVE
POH Phosphagenics' PHN Trial Completes Enrolment and Dosing
17/12/15PRICE SENSITIVE
POH Change of Company Secretary
04/12/15
POH Phosphagenics Initiates Grower/Finisher Pig Study
03/12/15PRICE SENSITIVE
POH Change in substantial holding
13/11/15
POH Receipt of R&D Tax Incentive
11/11/15PRICE SENSITIVE
POH Change in substantial holding
09/11/15
POH Phosphagenics Investor presentation - Australian Roadshow
04/11/15
POH Change in substantial holding
02/11/15
POH Phosphagenics - October 2015 Newsletter
28/10/15
POH Quarterly Shareholder Update teleconference
23/10/15
POH Development Agreement for TPM Oxymorphone Patch
22/10/15PRICE SENSITIVE
POH Phosphagenics Restructures
12/10/15PRICE SENSITIVE
POH Phosphagenics Begins Animal Health & Nutrition Program
28/09/15PRICE SENSITIVE
POH June 2015 Half-year Appendix 4D and Financial report
31/08/15PRICE SENSITIVE
POH Appendix 3Y Change in Directors Interest Dr R Murdoch
06/08/15
POH Reconciliation of Non-quoted Securities and Appendix 3B
06/08/15
POH Appendix 3Z - Final Directors Interest Notice - Mr H Rosen
10/07/15
POH Phosphagenics July 2015 Newsletter
09/07/15
POH Executive Director and Founder Steps Down
08/07/15
POH POH - Quarterly Shareholder Update - Teleconference
01/07/15
POH Appointment of Consultant to Assist in Commercialising TPM
09/06/15
POH 2015 Annual General Meeting Results
19/05/15
POH 2015 AGM Chairmans and CEO Presentations
18/05/15
POH Final Directors Interest Notice - Appendix 3Z
14/05/15
POH Oxymorphone Patch Program Update
14/05/15PRICE SENSITIVE
POH Resignation of Chairman - Mr L Gozlan
12/05/15
POH 2014 Annual Report and 2015 AGM documentation
17/04/15
POH Appendix 3X Notices - 3
17/04/15
POH POH Oxycodone Patch Dosing in Phase 2 Clinical Trial
17/04/15PRICE SENSITIVE
POH Phosphagenics Appoints Three New Directors
13/04/15
POH Animal Health Nutrition License Agreement signed
25/03/15PRICE SENSITIVE
POH Response to ASX Price Query
12/03/15PRICE SENSITIVE
POH December 2014 Preliminary Final Report and Financial Report
26/02/15PRICE SENSITIVE
POH POH Decides to Put its BioElixia Cosmetic Brand Up For Sale
25/02/15PRICE SENSITIVE
POH Phosphagenics Appoints Dr Ross Murdoch as CEO
14/01/15PRICE SENSITIVE
POH Ethics Approval -Topical Phase 2 TPM Oxycodone Patch Trial
08/12/14PRICE SENSITIVE
POH Phosphagenics November Newsletter
05/11/14
POH Phosphagenics Launches New Logo and Website
05/11/14
POH Director's Change of Interest Notice - Dr G Cauwenbergh
15/10/14
POH Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne
07/10/14PRICE SENSITIVE
POH Form 604 Change Substantial Shareholding Mr H Rosen
01/09/14
POH Section 708A Notice - Equity Raising - 51 million new shares
01/09/14
POH Confirmation - Allotment of 51 million new ordinary shares
01/09/14
POH June 2014 App 4D Half Yearly Report and Financial Report
27/08/14PRICE SENSITIVE
POH General Meeting Results
26/08/14
POH First IND Enabling Study for TPM Oxymorphone Completed
11/08/14PRICE SENSITIVE
POH Allotment of Share Purchase Plan New Shares
06/08/14
POH Share Purchase Plan Closed Oversubscribed
05/08/14
POH Opioid Patch Program Update
28/07/14PRICE SENSITIVE
POH Share Purchase Plan Extension of Closing Date to 01 08 14
25/07/14
POH General Meeting Documentation - Proxy Form
25/07/14
POH Form 605 Notice of ceasing to be a substantial shareholder
23/07/14
POH Section 708A Notice - Equity Raising - 153 million shares
18/07/14
POH Confirmation - allotment of 153 million new shares
18/07/14
POH POH - Share Purchase Plan documentation
15/07/14
POH POH - SPP - Notice Under ASIC Class Order 09-425
11/07/14
POH Phosphagenics Appendix 3B Notice - Equity Capital Raising
11/07/14
POH Phosphagenics $19.3 million Capital raising
11/07/14PRICE SENSITIVE
POH Trading Halt
09/07/14PRICE SENSITIVE
POH Strengthens Partnership with Le Metier de Beaute Cosmetics
12/06/14
POHAppendix 3Y Notices -3- Change in Directors Interest
03/06/14
POHAppendix 3B Notice - Issue of Options to Directors
03/06/14
POH2014 AGM Results
23/05/14
POH2014 AGM Addresses - Presentations
23/05/14
POHPOH Topical Oxycodone Patch Alleviates Pain in Racehorses
21/05/14PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.